Related Experiment Videos
[Fusarium pleural effusion after a ventricular assist device]
J Villacorta1, A Blancard, F Kerbaul
1Département d'anesthésie-réanimation Adultes, CHU Timone, 264, rue Saint-Pierre, 13385 Marseille, Paris, France. jvillacortatorres@mail.ap-hm.fr
Annales Francaises D'Anesthesie Et De Reanimation
|June 25, 2002
Summary
A rare Fusarium infection complicated a patient's recovery after ventricular assist device (VAD) implantation. Successful treatment involved liposomal amphotericin B and 5-fluorocytosine, leading to complete recovery.
Area of Science:
- Medicine
- Infectious Diseases
- Cardiology
Background:
- Ventricular assist devices (VADs) are crucial for end-stage heart failure management.
- Postoperative complications, including infections, can arise after VAD implantation.
- Fungal infections, though rare, pose a significant threat in immunocompromised patients.
Observation:
- A 36-year-old male developed a pleural effusion post-VAD surgery.
- The effusion was diagnosed as a Fusarium infection, a rare but serious complication.
- This case highlights the potential for invasive fungal infections in VAD recipients.
Findings:
- Epidemiological, etiologic, and therapeutic aspects of Fusarium infections were reviewed.
- The patient received treatment with liposomal amphotericin B (AmBisome) and 5-fluorocytosine.
- Complete resolution of the Fusarium infection was achieved with this combination therapy.
Implications:
- This case underscores the importance of considering rare fungal pathogens in VAD-related infections.
- Effective treatment strategies for Fusarium infections in VAD patients can be established.
- Early diagnosis and prompt, aggressive antifungal therapy are critical for favorable outcomes in VAD recipients.